speb/financial-data huggingface dataset:
SURG.V cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -3354.00
SURG.V balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 44700301.00
SURG.V balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 4320000.00
SURG.V balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 4320000.00
SURG.V income_statement (annual, 2023-03-31) — Normalized EBITDA: -1814092.00
SURG.V income_statement (annual, 2023-03-31) — Normalized Income: -2112414.00
SURG.V cash_flow (annual, 2023-03-31) — Operating Cash Flow: -871360.00
SURG.V income_statement (annual, 2023-03-31) — Operating Income: -3354467.00
SURG.V income_statement (annual, 2023-03-31) — Operating Revenue: 0.00
SURG.V balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 194547412.00
SURG.V balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 911551.00
SURG.V income_statement (annual, 2023-03-31) — Other Gand A: 1109378.00
SURG.V income_statement (annual, 2023-03-31) — Other Income Expense: 1433793.00
SURG.V cash_flow (annual, 2023-03-31) — Other Non Cash Items: -1406193.00
SURG.V income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 1433793.00
SURG.V income_statement (annual, 2023-03-31) — Other Operating Expenses: 132048.00
SURG.V balance_sheet (annual, 2023-03-31) — Other Properties: 47285395.00
SURG.V income_statement (annual, 2023-03-31) — Other Taxes: 40663.00
SURG.V balance_sheet (annual, 2023-03-31) — Payables: 287625.00
SURG.V balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 313625.00
SURG.V balance_sheet (annual, 2023-03-31) — Prepaid Assets: 107749.00
SURG.V income_statement (annual, 2023-03-31) — Pretax Income: -1866414.00
SURG.V cash_flow (annual, 2023-03-31) — Purchase Of PPE: -3354.00
SURG.V balance_sheet (annual, 2023-03-31) — Receivables: 39645.00
SURG.V income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 39333.00
SURG.V income_statement (annual, 2023-03-31) — Reconciled Depreciation: 39333.00
SURG.V cash_flow (annual, 2023-03-31) — Repayment Of Debt: -21080.00
SURG.V balance_sheet (annual, 2023-03-31) — Retained Earnings: -31362119.00
SURG.V income_statement (annual, 2023-03-31) — Salaries And Wages: 1880735.00
SURG.V income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 152310.00
SURG.V income_statement (annual, 2023-03-31) — Selling General And Administration: 3142423.00
SURG.V balance_sheet (annual, 2023-03-31) — Share Issued: 194547412.00
SURG.V cash_flow (annual, 2023-03-31) — Stock Based Compensation: 1880735.00
SURG.V balance_sheet (annual, 2023-03-31) — Stockholders Equity: 44700301.00
SURG.V balance_sheet (annual, 2023-03-31) — Tangible Book Value: 44700301.00
SURG.V income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
SURG.V income_statement (annual, 2023-03-31) — Tax Provision: 246000.00
SURG.V income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.40
SURG.V balance_sheet (annual, 2023-03-31) — Taxes Receivable: 39645.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Assets: 50350510.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Capitalization: 44700301.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Debt: 105033.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 44700301.00
SURG.V income_statement (annual, 2023-03-31) — Total Expenses: 3354467.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 5650209.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 47381121.00
SURG.V balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 4400367.00
SURG.V balance_sheet (annual, 2023-03-31) — Working Capital: 1719547.00
SURG.V income_statement (annual, 2024-03-31) — +Operating Expense: 2662709.00
SURG.V income_statement (annual, 2024-03-31) — +Total Revenue: 0.00
SURG.V balance_sheet (annual, 2024-03-31) — Accounts Payable: 208796.00
SURG.V balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -127948.00
SURG.V balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 13059226.00
SURG.V cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 36064.00
SURG.V cash_flow (annual, 2024-03-31) — Amortization Of Intangibles: 36064.00
SURG.V income_statement (annual, 2024-03-31) — Basic Average Shares: 202097771.00
SURG.V income_statement (annual, 2024-03-31) — Basic EPS: -0.01
SURG.V cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2821995.00
SURG.V balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 67806.00
SURG.V cash_flow (annual, 2024-03-31) — Capital Expenditure: -9488.00
SURG.V balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 80367.00
SURG.V balance_sheet (annual, 2024-03-31) — Capital Stock: 66465142.00
SURG.V balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 84658.00
SURG.V balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 84658.00
SURG.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 144250.00
SURG.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -2031832.00
SURG.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -849755.00
SURG.V cash_flow (annual, 2024-03-31) — Change In Payable: 416978.00
SURG.V cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 416978.00
SURG.V cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 19697.00
SURG.V cash_flow (annual, 2024-03-31) — Change In Receivables: 21509.00
SURG.V cash_flow (annual, 2024-03-31) — Change In Working Capital: 458184.00
SURG.V cash_flow (annual, 2024-03-31) — Changes In Cash: -2737337.00
SURG.V balance_sheet (annual, 2024-03-31) — Common Stock: 66465142.00
SURG.V balance_sheet (annual, 2024-03-31) — Common Stock Equity: 46427660.00
SURG.V cash_flow (annual, 2024-03-31) — Common Stock Issuance: 168916.00
SURG.V income_statement (annual, 2024-03-31) — Cost Of Revenue: 36064.00
SURG.V balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 26000.00
SURG.V balance_sheet (annual, 2024-03-31) — Current Assets: 190846.00
SURG.V balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 28733.00
SURG.V balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 28733.00
SURG.V balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 0.00
SURG.V balance_sheet (annual, 2024-03-31) — Current Liabilities: 850550.00
SURG.V cash_flow (annual, 2024-03-31) — Deferred Income Tax: -309000.00
SURG.V cash_flow (annual, 2024-03-31) — Deferred Tax: -309000.00
SURG.V cash_flow (annual, 2024-03-31) — Depreciation: 36064.00
SURG.V cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 36064.00
SURG.V cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 36064.00
SURG.V income_statement (annual, 2024-03-31) — Diluted Average Shares: 202097771.00
SURG.V income_statement (annual, 2024-03-31) — Diluted EPS: -0.01
SURG.V income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -1734589.00
SURG.V balance_sheet (annual, 2024-03-31) — Dueto Related Parties Current: 272898.00
SURG.V income_statement (annual, 2024-03-31) — EBIT: -2033168.00
SURG.V income_statement (annual, 2024-03-31) — EBITDA: -1997104.00
SURG.V cash_flow (annual, 2024-03-31) — End Cash Position: 84658.00
SURG.V cash_flow (annual, 2024-03-31) — Financing Cash Flow: 144250.00
SURG.V cash_flow (annual, 2024-03-31) — Free Cash Flow: -859243.00
SURG.V income_statement (annual, 2024-03-31) — General And Administrative Expense: 2351706.00
SURG.V balance_sheet (annual, 2024-03-31) — Gross PPE: 51277946.00
SURG.V income_statement (annual, 2024-03-31) — Gross Profit: -36064.00
SURG.V income_statement (annual, 2024-03-31) — Interest Expense: 10421.00
SURG.V income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 10421.00
SURG.V income_statement (annual, 2024-03-31) — Interest Income: 41777.00
SURG.V income_statement (annual, 2024-03-31) — Interest Income Non Operating: 41777.00
SURG.V balance_sheet (annual, 2024-03-31) — Invested Capital: 46427660.00
SURG.V cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2031832.00
SURG.V cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 168916.00
SURG.V balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 51634.00
SURG.V balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 51634.00
SURG.V cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -24666.00
SURG.V balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 152659.00
SURG.V cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 168916.00
SURG.V income_statement (annual, 2024-03-31) — Net Income: -1734589.00
SURG.V income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -1734589.00
SURG.V income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -1734589.00
SURG.V income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -1734589.00
SURG.V income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -1734589.00
SURG.V cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -1734589.00
SURG.V income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -1734589.00
SURG.V income_statement (annual, 2024-03-31) — Net Interest Income: 31356.00
SURG.V cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -24666.00
SURG.V cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -24666.00
SURG.V income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 31356.00
SURG.V cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -2022344.00
SURG.V balance_sheet (annual, 2024-03-31) — Net PPE: 51149998.00
SURG.V cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -9488.00
SURG.V balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 46427660.00
SURG.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 4011000.00
SURG.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 4011000.00
SURG.V income_statement (annual, 2024-03-31) — Normalized EBITDA: -1997104.00
SURG.V income_statement (annual, 2024-03-31) — Normalized Income: -1734589.00
SURG.V cash_flow (annual, 2024-03-31) — Operating Cash Flow: -849755.00
SURG.V income_statement (annual, 2024-03-31) — Operating Income: -2698773.00
SURG.V income_statement (annual, 2024-03-31) — Operating Revenue: 0.00
SURG.V balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 224449345.00
SURG.V balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 314123.00
SURG.V income_statement (annual, 2024-03-31) — Other Gand A: 1054692.00
SURG.V income_statement (annual, 2024-03-31) — Other Income Expense: 623828.00
SURG.V cash_flow (annual, 2024-03-31) — Other Non Cash Items: -597428.00
SURG.V income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 623828.00
SURG.V income_statement (annual, 2024-03-31) — Other Operating Expenses: 150542.00
SURG.V balance_sheet (annual, 2024-03-31) — Other Properties: 51057481.00
SURG.V balance_sheet (annual, 2024-03-31) — Other Receivables: 4400.00
SURG.V income_statement (annual, 2024-03-31) — Other Taxes: 0.00
SURG.V balance_sheet (annual, 2024-03-31) — Payables: 481694.00
SURG.V balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 507694.00
SURG.V balance_sheet (annual, 2024-03-31) — Prepaid Assets: 88052.00
SURG.V income_statement (annual, 2024-03-31) — Pretax Income: -2043589.00
SURG.V cash_flow (annual, 2024-03-31) — Purchase Of PPE: -9488.00
SURG.V balance_sheet (annual, 2024-03-31) — Receivables: 18136.00
SURG.V income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 36064.00
SURG.V income_statement (annual, 2024-03-31) — Reconciled Depreciation: 36064.00
SURG.V cash_flow (annual, 2024-03-31) — Repayment Of Debt: -24666.00
SURG.V balance_sheet (annual, 2024-03-31) — Retained Earnings: -33096708.00
SURG.V income_statement (annual, 2024-03-31) — Salaries And Wages: 1297014.00
SURG.V income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 160461.00
SURG.V income_statement (annual, 2024-03-31) — Selling General And Administration: 2512167.00
SURG.V balance_sheet (annual, 2024-03-31) — Share Issued: 224449345.00
SURG.V cash_flow (annual, 2024-03-31) — Stock Based Compensation: 1297014.00
SURG.V balance_sheet (annual, 2024-03-31) — Stockholders Equity: 46427660.00
SURG.V balance_sheet (annual, 2024-03-31) — Tangible Book Value: 46427660.00
SURG.V income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
SURG.V income_statement (annual, 2024-03-31) — Tax Provision: -309000.00
SURG.V income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.15
SURG.V balance_sheet (annual, 2024-03-31) — Taxes Receivable: 13736.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Assets: 51340844.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Capitalization: 46427660.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Debt: 80367.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 46427660.00
SURG.V income_statement (annual, 2024-03-31) — Total Expenses: 2698773.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 4913184.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 51149998.00
SURG.V balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 4062634.00
SURG.V balance_sheet (annual, 2024-03-31) — Working Capital: -659704.00
SURG.V cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 8235.00
SURG.V cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 8235.00
SURG.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 195904980.00
SURG.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
SURG.V cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -2858878.00
SURG.V cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: -7183.00
SURG.V cash_flow (quarterly, 2024-09-30) — Depreciation: 8235.00
SURG.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 195904980.00
SURG.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
SURG.V balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 37268.00
SURG.V cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -12171.00
SURG.V cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -2858878.00
SURG.V cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: -1057589.00
SURG.V cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -2858878.00
SURG.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 895239.00
SURG.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 233650.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -174305.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 14069402.00
SURG.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 287958552.00
SURG.V income_statement (quarterly, 2024-12-31) — Basic EPS: 0.00
SURG.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 3676936.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 47464.00
SURG.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -521676.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 58817.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 73110216.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 2571922.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2571922.00
SURG.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
SURG.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -521676.00
SURG.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -583339.00
SURG.V cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -7184.00
SURG.V cash_flow (quarterly, 2024-12-31) — Change In Payable: -63860.00
SURG.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -63860.00
SURG.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 50793.00
SURG.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -35446.00
SURG.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -55697.00
SURG.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: -1105015.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 73110216.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 52952957.00
SURG.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
SURG.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 8235.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 45500.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 2852818.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 28733.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 28733.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 382868.00
SURG.V cash_flow (quarterly, 2024-12-31) — Depreciation: 8235.00
SURG.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 8235.00
SURG.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 8235.00
SURG.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 287958552.00
SURG.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.00
SURG.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -874492.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 74985.00
SURG.V income_statement (quarterly, 2024-12-31) — EBIT: -872649.00
SURG.V income_statement (quarterly, 2024-12-31) — EBITDA: -864414.00
SURG.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 2571921.00
SURG.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 0.00
SURG.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -1105015.00
SURG.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 371715.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 54698396.00
SURG.V income_statement (quarterly, 2024-12-31) — Gross Profit: -8235.00
SURG.V income_statement (quarterly, 2024-12-31) — Interest Expense: 1843.00
SURG.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1843.00
SURG.V income_statement (quarterly, 2024-12-31) — Interest Income: 24225.00
SURG.V income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 24225.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 52952957.00
SURG.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -521676.00
SURG.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 30084.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 30084.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 194651.00
SURG.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Income: -874492.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -874492.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -874492.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -874492.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -874492.00
SURG.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -874492.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -874492.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Interest Income: 22382.00
SURG.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 22382.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 54524091.00
SURG.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -521676.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 52952957.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 4011000.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 4011000.00
SURG.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -864414.00
SURG.V income_statement (quarterly, 2024-12-31) — Normalized Income: -874492.00
SURG.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -583339.00
SURG.V income_statement (quarterly, 2024-12-31) — Operating Income: -903474.00
SURG.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 288518589.00
SURG.V income_statement (quarterly, 2024-12-31) — Other Gand A: 33100.00
SURG.V income_statement (quarterly, 2024-12-31) — Other Income Expense: 6600.00
SURG.V income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 6600.00
SURG.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 499878.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 54456281.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Other Receivables: 8820.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Payables: 308635.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 354135.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 71783.00
SURG.V income_statement (quarterly, 2024-12-31) — Pretax Income: -874492.00
SURG.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -521676.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Receivables: 209113.00
SURG.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 8235.00
SURG.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 8235.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -34226661.00
SURG.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 338615.00
SURG.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 23646.00
SURG.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 395361.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 288518589.00
SURG.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 338615.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 52952957.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 52952957.00
SURG.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SURG.V income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
SURG.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 200293.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 57376909.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 52952957.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 58817.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 52952957.00
SURG.V income_statement (quarterly, 2024-12-31) — Total Expenses: 903474.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 4423952.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 54524091.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 4041084.00
SURG.V balance_sheet (quarterly, 2024-12-31) — Working Capital: 2469950.00
SURG.V income_statement (annual, 2025-03-31) — +Operating Expense: 3162316.00
SURG.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 786864.00
SURG.V income_statement (annual, 2025-03-31) — +Total Revenue: 0.00
SURG.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
SURG.V balance_sheet (annual, 2025-03-31) — Accounts Payable: 289659.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 289659.00
SURG.V balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -133767.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -133767.00
SURG.V balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 13530838.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 13530838.00
SURG.V cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 32941.00
SURG.V cash_flow (annual, 2025-03-31) — Amortization Of Intangibles: 32941.00
SURG.V income_statement (annual, 2025-03-31) — Basic Average Shares: 277517277.00
SURG.V income_statement (annual, 2025-03-31) — Basic EPS: -0.01
SURG.V cash_flow (annual, 2025-03-31) — Beginning Cash Position: 84658.00
SURG.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2571921.00
SURG.V balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 40684.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 40684.00
SURG.V cash_flow (annual, 2025-03-31) — Capital Expenditure: -17283.00
SURG.V balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 51634.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 51634.00
SURG.V balance_sheet (annual, 2025-03-31) — Capital Stock: 74060417.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 74060417.00
SURG.V balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1881003.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1881003.00
SURG.V balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1881003.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1881003.00
SURG.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 7285694.00
SURG.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -28734.00
SURG.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3560382.00
SURG.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -161582.00
SURG.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1928967.00
SURG.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -500602.00
SURG.V cash_flow (annual, 2025-03-31) — Change In Payable: -132772.00
SURG.V cash_flow (quarterly, 2025-03-31) — Change In Payable: -161693.00
SURG.V cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: -132772.00
SURG.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -161693.00
SURG.V cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: 5043.00
SURG.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -11226.00
SURG.V cash_flow (annual, 2025-03-31) — Change In Receivables: -215257.00
SURG.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -24280.00
SURG.V cash_flow (annual, 2025-03-31) — Change In Working Capital: -342986.00
SURG.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -175649.00
SURG.V cash_flow (annual, 2025-03-31) — Changes In Cash: 1796345.00
SURG.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -690918.00
SURG.V balance_sheet (annual, 2025-03-31) — Common Stock: 74060417.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 74060417.00
SURG.V balance_sheet (annual, 2025-03-31) — Common Stock Equity: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 52443146.00
SURG.V cash_flow (annual, 2025-03-31) — Common Stock Issuance: 7364661.00
SURG.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 50233.00
SURG.V income_statement (annual, 2025-03-31) — Cost Of Revenue: 32941.00
SURG.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 8236.00
SURG.V balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 26000.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 26000.00
SURG.V balance_sheet (annual, 2025-03-31) — Current Assets: 2197405.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 2197405.00
SURG.V balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 33262.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 33262.00
SURG.V balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 33262.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 33262.00
SURG.V balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 43621.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 43621.00
SURG.V balance_sheet (annual, 2025-03-31) — Current Liabilities: 411356.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 411356.00
SURG.V cash_flow (annual, 2025-03-31) — Deferred Income Tax: 133000.00
SURG.V cash_flow (annual, 2025-03-31) — Deferred Tax: 133000.00
SURG.V cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 32941.00
SURG.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 8236.00
SURG.V cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 32941.00
SURG.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 8236.00
SURG.V income_statement (annual, 2025-03-31) — Diluted Average Shares: 277517277.00
SURG.V income_statement (annual, 2025-03-31) — Diluted EPS: -0.01
SURG.V income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -921448.00
SURG.V balance_sheet (annual, 2025-03-31) — Dueto Related Parties Current: 18814.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 18814.00
SURG.V income_statement (annual, 2025-03-31) — EBIT: -1911030.00
SURG.V income_statement (quarterly, 2025-03-31) — EBIT: -786605.00
SURG.V income_statement (annual, 2025-03-31) — EBITDA: -1878089.00
SURG.V income_statement (quarterly, 2025-03-31) — EBITDA: -778369.00
SURG.V cash_flow (annual, 2025-03-31) — End Cash Position: 1881003.00
SURG.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 1881003.00
SURG.V cash_flow (annual, 2025-03-31) — Financing Cash Flow: 7285694.00
SURG.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -28734.00
SURG.V cash_flow (annual, 2025-03-31) — Free Cash Flow: -1946250.00
SURG.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 2880915.00
SURG.V income_statement (annual, 2025-03-31) — General And Administrative Expense: 2731696.00
SURG.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1425521.00
SURG.V balance_sheet (annual, 2025-03-31) — Gross PPE: 54953236.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 54953236.00
SURG.V income_statement (annual, 2025-03-31) — Gross Profit: -32941.00
SURG.V income_statement (quarterly, 2025-03-31) — Gross Profit: -8236.00
SURG.V income_statement (annual, 2025-03-31) — Interest Expense: 7371.00
SURG.V income_statement (quarterly, 2025-03-31) — Interest Expense: 1843.00
SURG.V income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 7371.00
SURG.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1843.00
SURG.V income_statement (annual, 2025-03-31) — Interest Income: 103200.00
SURG.V income_statement (quarterly, 2025-03-31) — Interest Income: 14106.00
SURG.V income_statement (annual, 2025-03-31) — Interest Income Non Operating: 103200.00
SURG.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 14106.00
SURG.V balance_sheet (annual, 2025-03-31) — Invested Capital: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 52443146.00
SURG.V cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3560382.00
SURG.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -161582.00
SURG.V cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 7364661.00
SURG.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 50233.00
SURG.V balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 18372.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 18372.00
SURG.V balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 18372.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 18372.00
SURG.V cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -28733.00
SURG.V balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 152659.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 152659.00
SURG.V cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 7364661.00
SURG.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 50233.00
SURG.V income_statement (annual, 2025-03-31) — Net Income: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Income: -921448.00
SURG.V income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -921448.00
SURG.V income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -921448.00
SURG.V income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -921448.00
SURG.V income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -921448.00
SURG.V cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -2051401.00
SURG.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -921448.00
SURG.V income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -921448.00
SURG.V income_statement (annual, 2025-03-31) — Net Interest Income: 95829.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 12263.00
SURG.V cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -28733.00
SURG.V cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -28733.00
SURG.V income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 95829.00
SURG.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 12263.00
SURG.V cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -50234.00
SURG.V cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -3543099.00
SURG.V balance_sheet (annual, 2025-03-31) — Net PPE: 54819469.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 54819469.00
SURG.V cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -17283.00
SURG.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 3381517.00
SURG.V balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 52443146.00
SURG.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 4144000.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4144000.00
SURG.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4144000.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4144000.00
SURG.V income_statement (annual, 2025-03-31) — Normalized EBITDA: -1878089.00
SURG.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -778369.00
SURG.V income_statement (annual, 2025-03-31) — Normalized Income: -2051401.00
SURG.V income_statement (quarterly, 2025-03-31) — Normalized Income: -921448.00
SURG.V cash_flow (annual, 2025-03-31) — Operating Cash Flow: -1928967.00
SURG.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -500602.00
SURG.V cash_flow (annual, 2025-03-31) — Operating Gains Losses: 10529.00
SURG.V income_statement (annual, 2025-03-31) — Operating Income: -3195257.00
SURG.V income_statement (quarterly, 2025-03-31) — Operating Income: -795100.00
SURG.V income_statement (annual, 2025-03-31) — Operating Revenue: 0.00
SURG.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
SURG.V balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 290979913.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 290979913.00
SURG.V income_statement (annual, 2025-03-31) — Other Gand A: 1276790.00
SURG.V income_statement (quarterly, 2025-03-31) — Other Gand A: 980791.00
SURG.V income_statement (annual, 2025-03-31) — Other Income Expense: 1181027.00
SURG.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -5611.00
SURG.V cash_flow (annual, 2025-03-31) — Other Non Cash Items: -1155427.00
SURG.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 10529.00
SURG.V income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1181027.00
SURG.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -5611.00
SURG.V income_statement (annual, 2025-03-31) — Other Operating Expenses: 159744.00
SURG.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -787538.00
SURG.V balance_sheet (annual, 2025-03-31) — Other Properties: 54759893.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 54759893.00
SURG.V balance_sheet (annual, 2025-03-31) — Other Receivables: 3780.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3780.00
SURG.V income_statement (annual, 2025-03-31) — Other Taxes: 8589.00
SURG.V balance_sheet (annual, 2025-03-31) — Payables: 308473.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Payables: 308473.00
SURG.V balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 334473.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 334473.00
SURG.V balance_sheet (annual, 2025-03-31) — Prepaid Assets: 83009.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 83009.00
SURG.V income_statement (annual, 2025-03-31) — Pretax Income: -1918401.00
SURG.V income_statement (quarterly, 2025-03-31) — Pretax Income: -788448.00
SURG.V cash_flow (annual, 2025-03-31) — Purchase Of PPE: -17283.00
SURG.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 3381517.00
SURG.V balance_sheet (annual, 2025-03-31) — Receivables: 233393.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Receivables: 233393.00
SURG.V income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 32941.00
SURG.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 8236.00
SURG.V income_statement (annual, 2025-03-31) — Reconciled Depreciation: 32941.00
SURG.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 8236.00
SURG.V cash_flow (annual, 2025-03-31) — Repayment Of Debt: -28733.00
SURG.V balance_sheet (annual, 2025-03-31) — Retained Earnings: -35148109.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -35148109.00
SURG.V income_statement (annual, 2025-03-31) — Salaries And Wages: 1454906.00
SURG.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 444730.00
SURG.V income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 262287.00
SURG.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 140292.00
SURG.V income_statement (annual, 2025-03-31) — Selling General And Administration: 2993983.00
SURG.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1565813.00
SURG.V balance_sheet (annual, 2025-03-31) — Share Issued: 290979913.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 290979913.00
SURG.V cash_flow (annual, 2025-03-31) — Stock Based Compensation: 1454906.00
SURG.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 444730.00
SURG.V balance_sheet (annual, 2025-03-31) — Stockholders Equity: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 52443146.00
SURG.V balance_sheet (annual, 2025-03-31) — Tangible Book Value: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 52443146.00
SURG.V income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SURG.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SURG.V income_statement (annual, 2025-03-31) — Tax Provision: 133000.00
SURG.V income_statement (quarterly, 2025-03-31) — Tax Provision: 133000.00
SURG.V income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.15
SURG.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
SURG.V balance_sheet (annual, 2025-03-31) — Taxes Receivable: 229613.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 229613.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Assets: 57016874.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 57016874.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Capitalization: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 52443146.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Debt: 51634.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 51634.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 52443146.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 52443146.00
SURG.V income_statement (annual, 2025-03-31) — Total Expenses: 3195257.00
SURG.V income_statement (quarterly, 2025-03-31) — Total Expenses: 795100.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4573728.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4573728.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 54819469.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 54819469.00
SURG.V balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4162372.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4162372.00
SURG.V balance_sheet (annual, 2025-03-31) — Working Capital: 1786049.00
SURG.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 1786049.00
SURG.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 636289.00
SURG.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 76291.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -134864.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 13771060.00
SURG.V cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 7878.00
SURG.V cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 7878.00
SURG.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 290979913.00
SURG.V income_statement (quarterly, 2025-06-30) — Basic EPS: -0.01
SURG.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1881003.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 44451.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 74060417.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1060737.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1060737.00
SURG.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
SURG.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -161507.00
SURG.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -658759.00
SURG.V cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -7183.00
SURG.V cash_flow (quarterly, 2025-06-30) — Change In Payable: -214237.00
SURG.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -214237.00
SURG.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -150895.00
SURG.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -13824.00
SURG.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -386139.00
SURG.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -820266.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 74060417.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 52032914.00
SURG.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
SURG.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 7878.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 32500.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 1541858.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 24947.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 24947.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 173355.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 318538.00
SURG.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7878.00
SURG.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7878.00
SURG.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 290979913.00
SURG.V income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.01
SURG.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -650454.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 11445.00
SURG.V income_statement (quarterly, 2025-06-30) — EBIT: -648611.00
SURG.V income_statement (quarterly, 2025-06-30) — EBITDA: -640733.00
SURG.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 1060737.00
SURG.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
SURG.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -658759.00
SURG.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 559149.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 55107962.00
SURG.V income_statement (quarterly, 2025-06-30) — Gross Profit: -7878.00
SURG.V income_statement (quarterly, 2025-06-30) — Interest Expense: 1843.00
SURG.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1843.00
SURG.V income_statement (quarterly, 2025-06-30) — Interest Income: 8208.00
SURG.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 8208.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 52032914.00
SURG.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -161507.00
SURG.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 19504.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 19504.00
SURG.V balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 152659.00
SURG.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Income: -650454.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -650454.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -650454.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -650454.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -650454.00
SURG.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -650454.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -650454.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Interest Income: 6365.00
SURG.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 6365.00